![]() ![]() These programs are often referred to as accumulator adjustment programs. Patients with these plan limitations are not eligible for the Repatha ® Co-Pay Card but may be eligible for other needs-based assistance provided by Amgen. The Repatha ® Co-Pay Card offer does not cover out-of-pocket costs for any patient whose selected coverage option under their commercial insurance plan does not apply Repatha ® Co-Pay Card payments to satisfy the patient’s co-payment, deductible, or co-insurance for Repatha ®. See PROGRAM DETAILS for full description. The Repatha ® Co-Pay Card helps provide out-of-pocket support to eligible patients for their Repatha ® prescription up to program limits. This offer is only valid in the United States, Puerto Rico, and the US territories. A patient is considered cash-paying where the patient has no insurance coverage for Repatha ® or where the patient has commercial or private insurance but Amgen in its sole discretion determines the patient is effectively uninsured because such coverage does not provide a material level of financial assistance for the cost of a Repatha ® prescription. It is not valid for cash-paying patients or where prohibited by law. This offer is not valid for patients whose Repatha ® prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state programs. There is no income requirement to participate in this program. This program helps eligible patients cover out-of-pocket costs related to Repatha ®, up to program limits. (See PROGRAM BENEFITS section below.)Įligibility Criteria: Subject to program limitations and terms and conditions, the Repatha ® Co-Pay Card is open to patients who have a Repatha ® prescription and who have commercial or private insurance, including plans available through state and federal healthcare exchanges. Please ask your Amgen SupportPlus Representative to help you understand eligibility for the Repatha ® Co-Pay Card, and whether your particular insurance coverage is likely to result in your reaching the Maximum Monthly Benefit, the Maximum Annual Program Benefit, or your Patient Total Program Benefit, by calling 1-844-REPATHA (1-84). Whether you are eligible to receive the Maximum Monthly Benefit, Maximum Program Benefit or Patient Total Program Benefit is determined by the type of plan coverage you have. ![]() If a patient’s commercial insurance plan imposes different or additional requirements on patients who receive Repatha ® Co-Pay Card benefits, Amgen has the right to modify or eliminate those benefits. The Repatha ® Co-Pay Card provides support up to the Maximum Monthly Benefit, the Maximum Annual Program Benefit and/or Patient Total Program Benefit.Offer is subject to change or discontinuation without notice.Patients are responsible for all amounts that exceed these limits. Amgen will pay the remaining eligible out-of-pocket costs on behalf of the patient up to a Maximum Monthly Benefit, a Maximum Annual Program Benefit and/or the Patient Total Program Benefit. Monthly out-of-pocket costs include co-payment, co-insurance, and deductible out-of-pocket costs. With the Repatha ® Co-Pay Card, a commercially insured patient who meets eligibility criteria may pay as little as a $5 Co-Pay per month for their Repatha ® monthly out-of-pocket costs.The program is not valid for patients whose Repatha ® prescription is paid for in whole or in part by Medicare, Medicaid, or any other federal or state healthcare program. The Repatha ® Co-Pay Card is open to patients with commercial insurance, regardless of financial need.The following summary is not a substitute for reviewing the Terms and Conditions in their entirety. It is important that every patient read and understand the full Repatha ® (evolocumab) Co-Pay Card Terms and Conditions. Repatha ® Co-Pay Card Terms and Conditions SUMMARY OF TERMS AND CONDITIONS ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |